Left Bundle Branch Block News Today : Breaking News, Live Updates & Top Stories | Vimarsana

A study conducted by researchers at Mayo Clinic, sponsored by the National Heart, Lung, and Blood Institute, found that early Cardiac Resynchronization Therapy (CRT) may slow the progression of heart failure in patients with mild to moderately reduced left ventricular ejection fraction (LVEF) and left bundle branch block (LBBB). The findings were presented during the final day of the Heart Rhythm Society meeting, HRS 2024, being held in Boston, MA.

Resynchronization therapy jumps forward with 3 new studies that support but push the envelope of a new guideline statement on physiologic pacing for heart failure.

Denmark: Aggressive blood pressure (BP) control is associated with a lower risk of left ventricular (LV) conduction disease, indicating that clinically relevant conduction disease may be preventable,...

Adaptive resynchronization therapy can benefit patients with heart failure, intact atrioventricular conduction, and left bundle branch block, even though the AdaptResponse trial technically failed.

Cardiac resynchronization extended survival during 5 extra years of follow-up of the RAFT study, which compared CRT-D with ICD defibrillation alone.